Court rules in favour of DuPont in Novozymes’ entitlement litigation

On 27 June 2019, the Danish Maritime and Commercial Court ruled in favour of Danisco’s ownership of the innovation behind two Danisco amylase patent applications (EP2859097 and EP2825643).


Legal argument

The court reasoned that Novozymes’ legal argument that an entitlement action could be based on prior art was without merit and awarded costs to Danisco.

Patent applications

‘Testimony from the trial clearly showed that the inventions claimed in these patent applications were based on Danisco technology and reflect our long history of innovation throughout the globe,’ says Wayne Ashton, global business director for home and personal care at DuPont.